nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenidol—Flavoxate—Raloxifene—breast cancer	0.26	0.27	CrCrCtD
Diphenidol—Dyclonine—Raloxifene—breast cancer	0.207	0.215	CrCrCtD
Diphenidol—Cloperastine—Raloxifene—breast cancer	0.0682	0.0709	CrCrCtD
Diphenidol—Loperamide—Toremifene—breast cancer	0.0576	0.0598	CrCrCtD
Diphenidol—Dextropropoxyphene—Toremifene—breast cancer	0.0473	0.0491	CrCrCtD
Diphenidol—Loperamide—Tamoxifen—breast cancer	0.0362	0.0376	CrCrCtD
Diphenidol—Levomethadyl Acetate—Tamoxifen—breast cancer	0.0362	0.0376	CrCrCtD
Diphenidol—Methadyl Acetate—Tamoxifen—breast cancer	0.0362	0.0376	CrCrCtD
Diphenidol—Clofedanol—Toremifene—breast cancer	0.0342	0.0355	CrCrCtD
Diphenidol—Benzphetamine—Toremifene—breast cancer	0.0331	0.0344	CrCrCtD
Diphenidol—Benzyl Benzoate—Toremifene—breast cancer	0.0307	0.0318	CrCrCtD
Diphenidol—Dextropropoxyphene—Tamoxifen—breast cancer	0.0297	0.0308	CrCrCtD
Diphenidol—Methadone—Tamoxifen—breast cancer	0.0248	0.0258	CrCrCtD
Diphenidol—Clofedanol—Tamoxifen—breast cancer	0.0215	0.0223	CrCrCtD
Diphenidol—Benzphetamine—Tamoxifen—breast cancer	0.0208	0.0216	CrCrCtD
Diphenidol—Benzyl Benzoate—Tamoxifen—breast cancer	0.0192	0.02	CrCrCtD
Diphenidol—Dyclonine—SCN10A—breast cancer	0.00112	0.183	CrCbGaD
Diphenidol—Clotrimazole—KCNN4—breast cancer	0.000995	0.162	CrCbGaD
Diphenidol—Flavoxate—PDE4D—breast cancer	0.000617	0.1	CrCbGaD
Diphenidol—Fexofenadine—SLCO1B1—breast cancer	0.000486	0.079	CrCbGaD
Diphenidol—Clotrimazole—CYP17A1—breast cancer	0.000342	0.0556	CrCbGaD
Diphenidol—Biperiden—CYP2D6—breast cancer	0.000204	0.0331	CrCbGaD
Diphenidol—Trospium—CYP2D6—breast cancer	0.000175	0.0284	CrCbGaD
Diphenidol—Clotrimazole—CYP19A1—breast cancer	0.000174	0.0283	CrCbGaD
Diphenidol—Levomethadyl Acetate—CYP19A1—breast cancer	0.000174	0.0283	CrCbGaD
Diphenidol—Biperiden—ABCB1—breast cancer	0.000145	0.0236	CrCbGaD
Diphenidol—Darifenacin—CYP2D6—breast cancer	0.000127	0.0206	CrCbGaD
Diphenidol—Fexofenadine—CYP2D6—breast cancer	0.000123	0.02	CrCbGaD
Diphenidol—Darifenacin—CYP3A4—breast cancer	0.000109	0.0177	CrCbGaD
Diphenidol—Methadone—CYP19A1—breast cancer	0.000102	0.0166	CrCbGaD
Diphenidol—Clotrimazole—CYP2D6—breast cancer	9.53e-05	0.0155	CrCbGaD
Diphenidol—Bepridil—CYP2D6—breast cancer	8.86e-05	0.0144	CrCbGaD
Diphenidol—Fexofenadine—ABCB1—breast cancer	8.81e-05	0.0143	CrCbGaD
Diphenidol—Dextropropoxyphene—CYP2D6—breast cancer	8.24e-05	0.0134	CrCbGaD
Diphenidol—Clotrimazole—CYP3A4—breast cancer	8.18e-05	0.0133	CrCbGaD
Diphenidol—Levomethadyl Acetate—CYP3A4—breast cancer	8.18e-05	0.0133	CrCbGaD
Diphenidol—Loperamide—CYP2D6—breast cancer	7.85e-05	0.0128	CrCbGaD
Diphenidol—Dextropropoxyphene—CYP3A4—breast cancer	7.07e-05	0.0115	CrCbGaD
Diphenidol—Fentanyl—CYP3A4—breast cancer	6.99e-05	0.0114	CrCbGaD
Diphenidol—Clotrimazole—ABCB1—breast cancer	6.81e-05	0.0111	CrCbGaD
Diphenidol—Loperamide—CYP3A4—breast cancer	6.73e-05	0.0109	CrCbGaD
Diphenidol—Bepridil—ABCB1—breast cancer	6.33e-05	0.0103	CrCbGaD
Diphenidol—Benzphetamine—CYP3A4—breast cancer	6.2e-05	0.0101	CrCbGaD
Diphenidol—Fentanyl—ABCB1—breast cancer	5.82e-05	0.00946	CrCbGaD
Diphenidol—Loperamide—ABCB1—breast cancer	5.61e-05	0.00911	CrCbGaD
Diphenidol—Methadone—CYP2D6—breast cancer	5.59e-05	0.00908	CrCbGaD
Diphenidol—Methadone—CYP3A4—breast cancer	4.79e-05	0.00779	CrCbGaD
Diphenidol—Methadone—ABCB1—breast cancer	3.99e-05	0.00649	CrCbGaD
Diphenidol—CHRM2—Signaling Pathways—ITPR1—breast cancer	7.88e-06	0.000251	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—MTHFR—breast cancer	7.85e-06	0.00025	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—STAT5A—breast cancer	7.82e-06	0.000249	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ERBB4—breast cancer	7.82e-06	0.000249	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MMP3—breast cancer	7.82e-06	0.000249	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3CB—breast cancer	7.8e-06	0.000248	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SMAD4—breast cancer	7.68e-06	0.000244	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SMAD4—breast cancer	7.65e-06	0.000244	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IGF1R—breast cancer	7.63e-06	0.000243	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IGF1R—breast cancer	7.61e-06	0.000242	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—CXCL8—breast cancer	7.6e-06	0.000242	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SMAD4—breast cancer	7.58e-06	0.000241	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—CXCL8—breast cancer	7.57e-06	0.000241	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IGF1R—breast cancer	7.53e-06	0.00024	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	7.5e-06	0.000239	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HES1—breast cancer	7.5e-06	0.000239	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HES1—breast cancer	7.47e-06	0.000238	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PLA2G4A—breast cancer	7.45e-06	0.000237	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NCOR1—breast cancer	7.45e-06	0.000237	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PLA2G4A—breast cancer	7.43e-06	0.000237	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NCOR1—breast cancer	7.43e-06	0.000237	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HES1—breast cancer	7.4e-06	0.000236	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FGF1—breast cancer	7.37e-06	0.000235	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CSF2—breast cancer	7.37e-06	0.000235	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NCOR1—breast cancer	7.36e-06	0.000234	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	7.36e-06	0.000234	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—RAF1—breast cancer	7.35e-06	0.000234	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CSF2—breast cancer	7.35e-06	0.000234	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FGF1—breast cancer	7.35e-06	0.000234	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—RAF1—breast cancer	7.33e-06	0.000233	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NRG1—breast cancer	7.32e-06	0.000233	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NRG1—breast cancer	7.29e-06	0.000232	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CSF2—breast cancer	7.27e-06	0.000232	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FGF1—breast cancer	7.27e-06	0.000232	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—H2AFX—breast cancer	7.26e-06	0.000231	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—IL2—breast cancer	7.26e-06	0.000231	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—RAF1—breast cancer	7.26e-06	0.000231	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—CAV1—breast cancer	7.24e-06	0.000231	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—H2AFX—breast cancer	7.24e-06	0.000231	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—IL2—breast cancer	7.24e-06	0.00023	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NRG1—breast cancer	7.22e-06	0.00023	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—E2F1—breast cancer	7.21e-06	0.00023	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—E2F1—breast cancer	7.19e-06	0.000229	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3CB—breast cancer	7.18e-06	0.000229	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—H2AFX—breast cancer	7.17e-06	0.000228	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—IL2—breast cancer	7.17e-06	0.000228	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	7.16e-06	0.000228	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—E2F1—breast cancer	7.12e-06	0.000227	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	7.09e-06	0.000226	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SPP1—breast cancer	6.93e-06	0.000221	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SPP1—breast cancer	6.91e-06	0.00022	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—CXCL8—breast cancer	6.9e-06	0.00022	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—CXCL8—breast cancer	6.88e-06	0.000219	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ERBB3—breast cancer	6.85e-06	0.000218	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FGFR2—breast cancer	6.84e-06	0.000218	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SPP1—breast cancer	6.84e-06	0.000218	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ERBB3—breast cancer	6.83e-06	0.000218	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FGFR2—breast cancer	6.82e-06	0.000217	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—CXCL8—breast cancer	6.81e-06	0.000217	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ERBB3—breast cancer	6.76e-06	0.000215	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FGFR2—breast cancer	6.75e-06	0.000215	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CG—breast cancer	6.6e-06	0.00021	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—IL2—breast cancer	6.59e-06	0.00021	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—IL2—breast cancer	6.57e-06	0.000209	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TERT—breast cancer	6.57e-06	0.000209	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TERT—breast cancer	6.55e-06	0.000208	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—IL2—breast cancer	6.51e-06	0.000207	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TERT—breast cancer	6.48e-06	0.000206	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FGFR1—breast cancer	6.38e-06	0.000203	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FGFR1—breast cancer	6.36e-06	0.000202	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FGFR1—breast cancer	6.3e-06	0.0002	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HIF1A—breast cancer	6.28e-06	0.0002	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HIF1A—breast cancer	6.26e-06	0.000199	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HIF1A—breast cancer	6.2e-06	0.000197	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—LEP—breast cancer	6.13e-06	0.000195	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—LEP—breast cancer	6.11e-06	0.000195	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CAV1—breast cancer	6.08e-06	0.000193	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CAV1—breast cancer	6.06e-06	0.000193	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—LEP—breast cancer	6.05e-06	0.000193	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KDR—breast cancer	6.01e-06	0.000191	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CAV1—breast cancer	6e-06	0.000191	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KDR—breast cancer	5.99e-06	0.000191	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KDR—breast cancer	5.93e-06	0.000189	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ESR1—breast cancer	5.85e-06	0.000186	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ESR1—breast cancer	5.84e-06	0.000186	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CD—breast cancer	5.8e-06	0.000185	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FN1—breast cancer	5.78e-06	0.000184	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ESR1—breast cancer	5.78e-06	0.000184	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FN1—breast cancer	5.76e-06	0.000184	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—ALB—breast cancer	5.73e-06	0.000182	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NFKBIA—breast cancer	5.71e-06	0.000182	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FN1—breast cancer	5.71e-06	0.000182	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NFKBIA—breast cancer	5.7e-06	0.000181	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NOTCH1—breast cancer	5.66e-06	0.00018	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NOTCH1—breast cancer	5.64e-06	0.00018	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NFKBIA—breast cancer	5.64e-06	0.00018	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NOTCH1—breast cancer	5.59e-06	0.000178	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KIT—breast cancer	5.53e-06	0.000176	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—APC—breast cancer	5.53e-06	0.000176	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CG—breast cancer	5.53e-06	0.000176	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CG—breast cancer	5.52e-06	0.000176	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—APC—breast cancer	5.52e-06	0.000176	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KIT—breast cancer	5.52e-06	0.000176	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—NOS3—breast cancer	5.48e-06	0.000174	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EGF—breast cancer	5.47e-06	0.000174	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CG—breast cancer	5.46e-06	0.000174	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—APC—breast cancer	5.46e-06	0.000174	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KIT—breast cancer	5.46e-06	0.000174	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EGF—breast cancer	5.45e-06	0.000174	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EGF—breast cancer	5.4e-06	0.000172	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—MAPK3—breast cancer	5.3e-06	0.000169	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—MAPK3—breast cancer	5.28e-06	0.000168	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—MAPK3—breast cancer	5.23e-06	0.000167	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—BRAF—breast cancer	5.2e-06	0.000166	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—BRAF—breast cancer	5.19e-06	0.000165	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—BRAF—breast cancer	5.13e-06	0.000163	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IGF1—breast cancer	5.07e-06	0.000161	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKT2—breast cancer	5.06e-06	0.000161	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CB—breast cancer	5.05e-06	0.000161	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IGF1—breast cancer	5.05e-06	0.000161	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKT2—breast cancer	5.05e-06	0.000161	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—EGFR—breast cancer	5.04e-06	0.000161	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—EGFR—breast cancer	5.03e-06	0.00016	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PTGS2—breast cancer	5.01e-06	0.000159	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IGF1—breast cancer	5e-06	0.000159	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKT2—breast cancer	5e-06	0.000159	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—EGFR—breast cancer	4.98e-06	0.000158	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CD—breast cancer	4.86e-06	0.000155	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CD—breast cancer	4.85e-06	0.000154	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PIK3CA—breast cancer	4.82e-06	0.000153	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SERPINE1—breast cancer	4.81e-06	0.000153	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	4.8e-06	0.000153	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CD—breast cancer	4.8e-06	0.000153	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SERPINE1—breast cancer	4.8e-06	0.000153	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—KRAS—breast cancer	4.76e-06	0.000152	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	4.76e-06	0.000151	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SERPINE1—breast cancer	4.75e-06	0.000151	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—KRAS—breast cancer	4.75e-06	0.000151	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—KRAS—breast cancer	4.7e-06	0.00015	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NOS3—breast cancer	4.59e-06	0.000146	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NOS3—breast cancer	4.58e-06	0.000146	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NOS3—breast cancer	4.53e-06	0.000144	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3CA—breast cancer	4.38e-06	0.000139	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PTEN—breast cancer	4.37e-06	0.000139	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	4.36e-06	0.000139	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MDM2—breast cancer	4.36e-06	0.000139	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MDM2—breast cancer	4.34e-06	0.000138	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—RAF1—breast cancer	4.34e-06	0.000138	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—RAF1—breast cancer	4.33e-06	0.000138	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—RELA—breast cancer	4.32e-06	0.000138	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	4.32e-06	0.000138	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—RELA—breast cancer	4.31e-06	0.000137	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MDM2—breast cancer	4.3e-06	0.000137	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ERBB2—breast cancer	4.3e-06	0.000137	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—RAF1—breast cancer	4.29e-06	0.000137	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ERBB2—breast cancer	4.28e-06	0.000136	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—RELA—breast cancer	4.27e-06	0.000136	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ERBB2—breast cancer	4.24e-06	0.000135	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CB—breast cancer	4.24e-06	0.000135	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MTOR—breast cancer	4.24e-06	0.000135	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MTOR—breast cancer	4.23e-06	0.000135	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CB—breast cancer	4.23e-06	0.000135	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MTOR—breast cancer	4.19e-06	0.000133	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CB—breast cancer	4.19e-06	0.000133	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CXCL8—breast cancer	4.07e-06	0.00013	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CXCL8—breast cancer	4.06e-06	0.000129	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—HRAS—breast cancer	4.05e-06	0.000129	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—HRAS—breast cancer	4.04e-06	0.000128	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CXCL8—breast cancer	4.02e-06	0.000128	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—HRAS—breast cancer	4e-06	0.000127	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CDKN1B—breast cancer	3.98e-06	0.000127	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CDKN1B—breast cancer	3.97e-06	0.000126	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—AKT1—breast cancer	3.94e-06	0.000125	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CDKN1B—breast cancer	3.93e-06	0.000125	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—AKT1—breast cancer	3.92e-06	0.000125	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CASP3—breast cancer	3.9e-06	0.000124	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IL2—breast cancer	3.89e-06	0.000124	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CASP3—breast cancer	3.89e-06	0.000124	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AKT1—breast cancer	3.89e-06	0.000124	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IL2—breast cancer	3.88e-06	0.000124	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—IL6—breast cancer	3.87e-06	0.000123	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—IL6—breast cancer	3.86e-06	0.000123	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CASP3—breast cancer	3.85e-06	0.000123	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IL2—breast cancer	3.84e-06	0.000122	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—IL6—breast cancer	3.82e-06	0.000122	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCND1—breast cancer	3.8e-06	0.000121	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—JUN—breast cancer	3.79e-06	0.000121	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCND1—breast cancer	3.78e-06	0.00012	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—JUN—breast cancer	3.78e-06	0.00012	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CTNNB1—breast cancer	3.76e-06	0.00012	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CTNNB1—breast cancer	3.75e-06	0.000119	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCND1—breast cancer	3.75e-06	0.000119	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—JUN—breast cancer	3.74e-06	0.000119	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CTNNB1—breast cancer	3.71e-06	0.000118	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MMP9—breast cancer	3.69e-06	0.000117	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MMP9—breast cancer	3.67e-06	0.000117	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CDKN1A—breast cancer	3.67e-06	0.000117	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PTEN—breast cancer	3.66e-06	0.000117	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CDKN1A—breast cancer	3.66e-06	0.000117	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PTEN—breast cancer	3.65e-06	0.000116	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MMP9—breast cancer	3.64e-06	0.000116	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CDKN1A—breast cancer	3.63e-06	0.000115	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PTEN—breast cancer	3.62e-06	0.000115	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MAPK8—breast cancer	3.58e-06	0.000114	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AKT1—breast cancer	3.57e-06	0.000114	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MAPK8—breast cancer	3.57e-06	0.000114	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AKT1—breast cancer	3.56e-06	0.000113	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MAPK8—breast cancer	3.54e-06	0.000113	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AKT1—breast cancer	3.53e-06	0.000112	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SRC—breast cancer	3.4e-06	0.000108	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SRC—breast cancer	3.39e-06	0.000108	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SRC—breast cancer	3.35e-06	0.000107	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—VEGFA—breast cancer	3.31e-06	0.000105	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—VEGFA—breast cancer	3.3e-06	0.000105	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—STAT3—breast cancer	3.28e-06	0.000104	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—VEGFA—breast cancer	3.27e-06	0.000104	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—STAT3—breast cancer	3.27e-06	0.000104	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—STAT3—breast cancer	3.23e-06	0.000103	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MAPK3—breast cancer	3.13e-06	9.97e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MAPK3—breast cancer	3.12e-06	9.94e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MAPK3—breast cancer	3.09e-06	9.84e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CA—breast cancer	3.08e-06	9.81e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MYC—breast cancer	3.04e-06	9.7e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TGFB1—breast cancer	3.04e-06	9.67e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MYC—breast cancer	3.04e-06	9.66e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TGFB1—breast cancer	3.03e-06	9.64e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MYC—breast cancer	3.01e-06	9.57e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TGFB1—breast cancer	3e-06	9.55e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EGFR—breast cancer	2.98e-06	9.48e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EGFR—breast cancer	2.97e-06	9.45e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EGFR—breast cancer	2.94e-06	9.36e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KRAS—breast cancer	2.81e-06	8.96e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KRAS—breast cancer	2.8e-06	8.93e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KRAS—breast cancer	2.78e-06	8.84e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CA—breast cancer	2.58e-06	8.23e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CA—breast cancer	2.58e-06	8.2e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CA—breast cancer	2.55e-06	8.12e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—AKT1—breast cancer	2.52e-06	8.02e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TP53—breast cancer	2.5e-06	7.96e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TP53—breast cancer	2.49e-06	7.94e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TP53—breast cancer	2.47e-06	7.86e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HRAS—breast cancer	2.39e-06	7.61e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HRAS—breast cancer	2.38e-06	7.59e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HRAS—breast cancer	2.36e-06	7.52e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IL6—breast cancer	2.29e-06	7.29e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IL6—breast cancer	2.28e-06	7.26e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IL6—breast cancer	2.26e-06	7.19e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKT1—breast cancer	2.11e-06	6.72e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKT1—breast cancer	2.1e-06	6.7e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKT1—breast cancer	2.08e-06	6.64e-05	CbGpPWpGaD
